(Q47331505)

14 January 2018

title

Epidemiology of prostate cancer in the Umbria region of Italy: evidence of opportunistic screening effects (English)

1 reference

14 January 2018

0 references

Francesco La Rosa

1

1 reference

14 January 2018

Fabrizio Stracci

series ordinal

2

1 reference

14 January 2018

Liliana Minelli

series ordinal

3

1 reference

14 January 2018

Vito Mastrandrea

series ordinal

4

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

14 January 2018

published in

Urology

1 reference

14 January 2018

volume

62

1 reference

14 January 2018

issue

6

1 reference

14 January 2018

page(s)

1040-1044

1 reference

14 January 2018

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Reply to Labrie et al. Results of the mortality analysis of the Quebec Randomized/controlled trial (RCT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

International trends in prostate-cancer mortality in the "PSA ERA".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Why is the prostate cancer death rate declining in the United States?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Lead-time in prostate cancer screening (Finland)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

American Cancer Society guidelines for the early detection of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Incidence, mortality and long-term survival from prostate cancer in Umbria, Italy, 1978-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Permutation tests for joinpoint regression with applications to cancer rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Relative survival and the estimation of net survival: elements for further discussion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Estimate of population coverage with the prostate specific antigen (PSA) test to screen for prostate cancer in a metropolitan area of northern Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Practice of opportunistic PSA screening in the Florence District

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Prostate cancer: population-based survival rates in central Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.07.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2003.07.007

1 reference

14 January 2018

1 reference

14 January 2018